Table: begin end state 1 29 cytoplasmic 30 52 transmembrane 53 64 non-cytoplasmic 65 84 transmembrane 85 94 cytoplasmic 95 114 transmembrane 115 120 non-cytoplasmic 121 142 transmembrane 143 152 cytoplasmic 153 174 transmembrane 175 179 non-cytoplasmic 180 204 transmembrane 205 252 cytoplasmic 253 282 transmembrane 283 300 non-cytoplasmic 301 321 transmembrane 322 329 cytoplasmic 330 346 transmembrane 347 351 non-cytoplasmic 352 370 transmembrane 371 389 cytoplasmic 390 414 transmembrane 415 420 non-cytoplasmic 421 442 transmembrane 443 448 cytoplasmic
Input: >Pf6N2E2_2838 FitnessBrowser__pseudo6_N2E2:Pf6N2E2_2838 MNQPQTSVGHCLDVQSFINAQPISRYQWRVVILCFLIVFLDGLDTAAMGFIAPALSQDWG IDRASLGPVMSAALIGMVFGALGSGPLADRFGRKVVLVGAVLLFGAFSLASAYSTNVDQL LVLRFLTGLGLGAGMPNATTLLSEYTPERKKSLLVTSMFCGFNLGMAGGGFISAKLIPAF GWHSLLLIGGILPLILAVVLLFWLPESARYLVVRNRGTDKVRKTLAPIDPNTVAQAASFS VPEQKTVKARNVLAVIFSGTYSAGTLLLWLTYFMGLVIVYLLTSWLPTLMRDSGASMEQA AFIGALFQFGGVLSAVGVGWAMDRFNPHKVIGLFYLMAGVFAYAVGQSLGNITLLATLVL VAGMCVNGAQSAMPSLAARFYPTQGRATGVSWMLGIGRFGAILGAWMGATLLGLGWNFEQ VLTALVIPAALATTAVVIKGMVSHADAT
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server